Crossmark

Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel

Crossref DOI link: https://doi.org/10.1007/s13555-023-00905-3

Published Online: 2023-03-16

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Papp, Kim A. https://orcid.org/0000-0001-9557-3642
Melosky, Barbara

Sehdev, Sandeep

Hotte, Sebastien J.

Beecker, Jennifer R.

Kirchhof, Mark G.

Turchin, Irina

Dutz, Jan P.

Gooderham, Melinda J.

Gniadecki, Robert

Hong, Chih-ho

Lambert, Jo

Lynde, Charles W.

Prajapati, Vimal H.

Vender, Ronald B.
Funding

Funding for this research was provided by:

AbbVie Canada

Amgen Canada

Janssen Canada

LEO Pharma

Novartis

SUN Pharma
License Information

Text and Data Mining valid from 2023-03-16

Version of Record valid from 2023-03-16
More Information

Article History

Received: 24 January 2023

Accepted: 15 February 2023

First Online: 16 March 2023

Change Date: 6 July 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s13555-023-00949-5

Updates are available Correction dated 2023-07-06

Click to view Correction: https://doi.org/10.1007/s13555-023-00949-5